Influence of large open-pit mines on the construction and optimization of urban ecological networks: A case study of Fushun City, China

Under the long-term effect of mineral resource exploitation, especially open-pit mining, ecosystems are severely disturbed. Constructing and optimizing urban ecological networks influenced by open-pit mines based on mine-city coordination helps integrate ecological restoration and the construction of urban ecological environments. We applied an InVEST model to Fushun City to evaluate urban ecosystem services under the influence of large open-pit mines. Twenty-one key patches important for maintaining landscape connectivity were screened as the ecological sources in the network, from which ecological resistance surfaces were constructed by combining the impacts of mines on the environment. Minimum cumulative resistance (MCR) and gravity models were then used to extract and classify ecological corridors favorable to species migration and diffusion. Fushun City had large spatial differences in ecosystem service functions, with high-value areas concentrated in the forest-rich Dongzhou District and the northern Shuncheng District. Under the influence of open-pit mining, the ecosystem service capacity of the region south of the Hunhe River was poor and lacked ecological sources. Urban ecological resistance surfaces reached a maximum in the open-pit mining area, and 210 ecological corridors were estimated using the MCR model, of which 46 were important. Only two corridors crossed the West and East open pit, forming two "ecological fracture surfaces." The Dongzhou and eastern Shuncheng districts had complex network structures and stable ecological environments. In contrast, the central and southern parts of Fushun City lacked ecological corridors owing to the influence of mining pits and gangue mountains, had simple network structures, and low connectivities with other sources. Combined with Fushun City's development plan, we propose that ecological network optimization should add new ecological source sites, reconstruct and repair ecological corridors, and upgrade ecological breakpoints. This study provides reference and basis for ecological network research in mining cities influenced by open-pit mines.

Game analysis on PPP model operation of abandoned mines ecological restoration under the innovation of central government's reward and punishment system in China

There is a huge funding gap in the abandoned mines ecological restoration in China. It is of great research value to explore how PPP model can better introduce social capital into the low-profit ecological restoration of abandoned mines. Based on the innovation perspective of the central government's reward and punishment system, this paper constructs an evolutionary game model of "local government-social capital", analyzes the interaction and behavior mechanism of core stakeholders in the operation process of abandoned mines ecological restoration PPP mode, and discusses the influence of evolutionary equilibrium strategy and parameters change on evolutionary strategy under different scenarios by Matlab simulation. The research shows that the abandoned mines ecological restoration needs the support of the central government. When the local government lightly punishes the low-quality service of social capital, the central government needs to pay higher costs to promote all parties to actively participate in the operation and supervision of the PPP project. The revenue and cost of government supervision, the operating subsidy for social capital and the cost saved by social capital in providing bad service are the key factors affecting the evolution of the game between government and social capital. Punishment can effectively spur social capital to keep the contract and operate in the project, but the punishment effect will be ineffective without government supervision. Finally, some suggestions are put forward, such as establishing a long-term supervision mechanism and a reasonable income mechanism for PPP projects, increasing penalties for violations, attracting third parties to reduce supervision costs and strengthening communication between the two parties, so as to make the project take into account the economic performance of social capital and the social welfare of government departments, and achieve dual Pareto improvement.

Association of WHSC1/NSD2 and T-cell infiltration with prostate cancer metastasis and prognosis

Progress in immunotherapy for prostate cancer (PCa) lags that for other cancers, mainly because of limited immune infiltration in PCa. This study aimed to assess the feasibility of NSD2 as an immunotherapeutic target in PCa. Immunohistochemistry was performed to evaluate the expression pattern of NSD2 in 34 cases of benign prostatic hyperplasia (BPH), 36 cases of prostatic intraepithelial neoplasia (PIN), and 57 cases of PCa, including 19 cases of metastatic castration-resistant prostatic cancer (mCRPC). Single-cell RNA sequencing and gene set enrichment analysis (GSEA) were used to correlate NSD2 with certain downstream pathways. Furthermore, the Immuno-Oncology-Biological-Research (IOBR) software package was used to analyze the potential roles of NSD2 in the tumor microenvironment. We found that the positive expression rate of NSD2 increased progressively in BPH, PIN and PCa. mCRPC had the highest staining intensity for NSD2. High NSD2 expression was positively correlated with the infiltration level of CD4+ tumor-infiltrating lymphocytes (TILs) and negatively correlated with that of CD8+ TILs. Importantly, a new immune classification based on NSD2 expression and CD4+ TILs and CD8+ TILs was successfully used to stratify PCa patients based on OS.PSA and CD4+ TILs are independent risk factors for PCa bone metastasis. This study demonstrates a novel role for NSD2 in defining immune infiltrate on in PCa and highlights the great potential for its application in immunotherapy response evaluation for prostate malignancies.

Influence of Fatty Acid Modification on the Anticancer Activity of the Antimicrobial Peptide Figainin 1

Antimicrobial peptides derived from the skin secretions of amphibians have made important progress in tumor therapy due to their unique mechanism of destroying cell membranes. Figainin 1 (F1) is an 18-amino acid antimicrobial peptide from the skin secretions of Boana raniceps frogs. In a previous study, F1 was shown to inhibit cancer cell proliferation. F1 is composed entirely of natural amino acids; therefore, it is easily degraded by a variety of proteases, resulting in poor stability and a short half-life. In the present study, we used a fatty acid modification strategy to improve the stability of Figainin 1. Among the 8 peptides synthesized, A-10 showed the strongest antiproliferative activity against K562 cells and the other four tumor cell lines, and its stability against serum and proteinase K was improved compared with F1. We found that A-10 works through two mechanisms, cell membrane destruction and apoptosis, and can arrest the cell cycle in the G0/G1 phase. Moreover, A-10 exhibited self-assembly behavior. Overall, it is necessary to select a fatty acid with a suitable length for modification to improve the stability and antiproliferative activity of antimicrobial peptides. This study provides a good reference for the development of antimicrobial peptides as effective anticancer compounds.

Glutaric Aciduria Type 1: Comparison between Diffusional Kurtosis Imaging and Conventional MR Imaging

BACKGROUND AND PURPOSE

Routine MR imaging has limited use in evaluating the severity of glutaric aciduria type 1. To better understand the mechanisms of brain injury in glutaric aciduria type 1, we explored the value of diffusional kurtosis imaging in detecting microstructural injury of the gray and white matter.

MATERIALS AND METHODS

This study included 17 patients with glutaric aciduria type 1 and 17 healthy controls who underwent conventional MR imaging and diffusional kurtosis imaging. The diffusional kurtosis imaging metrics of the gray and white matter were measured. Then, the MR imaging scores and diffusional kurtosis imaging metrics of all ROIs were further correlated with the morbidity scores and Barry-Albright dystonia scores.

RESULTS

The MR imaging scores showed no significant relation to the morbidity and Barry-Albright dystonia scores. Compared with healthy controls, patients with glutaric aciduria type 1 showed higher kurtosis values in the basal ganglia, corona radiata, centrum semiovale, and temporal lobe (P < .05). The DTI metrics of the basal ganglia were higher than those of healthy controls (P < .05). The fractional anisotropy value of the temporal lobe and the mean diffusivity values of basal ganglia in glutaric aciduria type 1 were lower than those in the control group (P < .05). The diffusional kurtosis imaging metrics of the temporal lobe and basal ganglia were significantly correlated with the Barry-Albright dystonia scores. The mean kurtosis values of the anterior and posterior putamen and Barry-Albright dystonia scores were most relevant (r = 0.721, 0.730, respectively). The mean kurtosis values of the basal ganglia had the best diagnostic efficiency with area under the curve values of 0.837 for the temporal lobe, and the mean diffusivity values of the basal ganglia in glutaric aciduria type 1 were lower than those in the control group (P < .05). The diffusional kurtosis imaging metrics of the temporal lobe and basal ganglia were significantly correlated with the Barry-Albright dystonia scores. The mean kurtosis values of the anterior and posterior putamen and Barry-Albright dystonia scores were most relevant (r = 0.721, 0.730, respectively). The mean kurtosis values of the basal ganglia had the best diagnostic efficiency with area under the curve values of 0.837.

CONCLUSIONS

Diffusional kurtosis imaging provides more comprehensive quantitative information regarding the gray and white matter micropathologic damage in glutaric aciduria type 1 than routine MR imaging scores.

Preoperative prediction of microvascular invasion and perineural invasion in pancreatic ductal adenocarcinoma with 18F-FDG PET/CT radiomics analysis

AIM

To develop and validate a predictive model based on 2-[¹⁸F]-fluoro-2-deoxy-d-glucose (¹⁸F-FDG) positron-emission tomography (PET)/computed tomography (CT) radiomics features and clinicopathological parameters to preoperatively identify microvascular invasion (MVI) and perineural invasion (PNI), which are important predictors of poor prognosis in patients with pancreatic ductal adenocarcinoma (PDAC).

MATERIALS AND METHODS

Preoperative ¹⁸F-FDG PET/CT images and clinicopathological parameters of 170 patients in PDAC were collected retrospectively. The whole tumour and its peritumoural variants (tumour dilated with 3, 5, and 10 mm pixels) were applied to add tumour periphery information. A feature-selection algorithm was employed to mine mono-modality and fused feature subsets, then conducted binary classification using gradient boosted decision trees.

RESULTS

For MVI prediction, the model performed best on a fused subset of ¹⁸F-FDG PET/CT radiomics features and two clinicopathological parameters, with an area under the receiver operating characteristic curve (AUC) of 83.08%, accuracy of 78.82%, recall of 75.08%, precision of 75.5%, and F1-score of 74.59%. For PNI prediction, the model achieved best prediction results only on the subset of PET/CT radiomics features, with AUC of 94%, accuracy of 89.33%, recall of 90%, precision of 87.81%, and F1 score of 88.35%. In both models, 3 mm dilation on the tumour volume produced the best results.

CONCLUSIONS

The radiomics predictors from preoperative ¹⁸F-FDG PET/CT imaging exhibited instructive predictive efficacy in the identification of MVI and PNI status preoperatively in PDAC. Peritumoural information was shown to assist in MVI and PNI predictions.

Rational Design of Molybdenum-Doped Cobalt Nitride Nanowire Arrays for Robust Overall Water Splitting

Rational design of efficient electrocatalysts is highly imperative but still a challenge for overall water splitting. Herein, we construct self-supported Co₃ N nanowire arrays with different Mo doping contents by hydrothermal and nitridation processes that serve as robust electrocatalysts for overall water splitting. The optimal Co₃ N-Mo_0.2 /Ni foam (NF) electrode delivers a low overpotential of 97 mV at a current density of 50 mA cm^-2 as well as a highly stable hydrogen evolution reaction (HER). Density functional theory (DFT) calculations prove that Mo doping can effectively modulate the electronic structure and surface adsorption energies of H₂ O and hydrogen intermediates on Co₃ N, leading to improved reaction kinetics with high catalytic activity. Further modification with FeOOH species on the surface of Co₃ N-Mo_0.2 /NF improves the oxygen evolution reaction (OER) performance benefiting from the synergistic effect of dual Co-Fe catalytic centers. As a result, the Co₃ N-Mo_0.2 @FeOOH/NF catalysts display outstanding OER catalytic performance with a low overpotential of 250 mV at 50 1 mA cm^-2 . The constructed Co₃ N-Mo_0.2 /NF||Co₃ N-Mo_0.2 @FeOOH/NF water electrolyzer exhibits a small voltage of 1.48 V to achieve a high current density of 50 mA cm^-2 at 80 °C, which is superior to most of the reported electrocatalysts. This work provides a new approach to developing robust electrode materials for electrocatalytic water splitting.

Engineering cobalt molybdate nanosheet arrays with phosphorus-modified nickel as heterogeneous electrodes for highly-active energy-saving water splitting

Electrochemical urea electrolysis has been regarded as a promising strategy to replace traditional water-splitting technology to achieve hydrogen fuel due to its cost savings and high energy efficiency. Designing efficient bifunctional electrocatalysts easily is important but still faces significant challenges. Herein, an interface engineering strategy is used to construct a hybrid material by coupling cobalt molybdate (CoMoO₄) nanosheet arrays with phosphorus-modified nickel (P-Ni) particles on copper foam (P-Ni@CoMoO₄/CF) through the hydrothermal and in-situ electrodeposition process. Benefiting from the abundant catalytic active sites, low charge transfer resistance, and synergistic coupling effect, the optimal P-Ni@CoMoO₄/CF electrocatalyst presents a superior bifunctional activity for urea oxidation reaction (UOR) and hydrogen evolution reaction (HER). In detail, a small overpotential of 125 mV and a low potential of 1.36 V is required to attain the current density of 100 mA cm^-2 for HER and UOR, respectively. In the process of urea electrolysis, the P-Ni@CoMoO₄/CF-based electrolyzer provides a current density of 100 mA cm^-2 with an overall voltage of 1.50 V, about 170 mV less than that in a traditional water electrolyzer. The high performance of P-Ni@CoMoO₄/CF outperforms many recently reported electrodes, suggesting its promising application in energy-saving hydrogen production. Our work proposes a novel idea for the rational design and exploitation of low-cost and robust bifunctional electrodes for electrocatalysis.

[Survival efficacy of MDS/AML patients with TP53 abnormal received allogeneic hematopoietic stem cell transplantation]

Objective: TP53-abnormal MDS/acute myeloid leukemia (AML) patients' allogeneic hematopoietic stem cell transplantation (allo-HSCT) treatment's effectiveness and influencing factors should be studied. Methods: 42 patients with TP53 gene status change MDS/AML who underwent allo-HSCT from 2014.8.1 to 2021.7.31 at the Hematology Hospital of the Chinese Academy of Medical Sciences were the subject of a retrospective analysis. The 42 patients were divided into three groups: the TP53 deletion group (group A) , TP53 mono-alle mutation group (group B) , and TP53 multi-hit group (group C) . The differences in clinical features and prognostic factors after transplantation were analyzed. Results: There were 42 MDS/AML patients, including 21 patients with MDS, and 21 patients with AML. The median follow-up period was 34.0 (7.5-75.0) months and the median patient age at the time of transplantation was 41.5 (18-63) years old. The total OS was 66.3% (95% CI 53.4%-82.4%) in 3 years after transplantation, and EFS was 61.0% (95% CI 47.7%-78.0%) in 3 years. For 3 years after receiving hematopoietic stem cell transplantation, there were no statistically significant differences in 3-year OS and EFS in groups A, B, and C (P≥0.05) . The 3 years OS was 82.5% (95% CI 63.1%-100.0%) in group A, 60.6% (95% CI 43.5%-84.4%) in group B, and 57.1% (95% CI 30.1%-100.0%) in group C. Univariate analysis revealed that the number of co-mutant genes, pre-HSCT treatment, and disease type did not affect prognosis, while age, karyotype, co-mutation, positive blast cell before transplantation, and positive blast cell after transplantation were common prognostic factors for OS and EFS (P<0.1) . MRD levels before transplantation were found to be independent risk factors for OS (P=0.037, HR=33.40, 95% CI 1.24-901.17) in a multivariate analysis. Conclusion: Patients with MDS/AML who have TP53 mutations can benefit from allo-HSCT, but patients with complex karyotypes have a worse prognosis. Meanwhile, the final flow cytometry (FCM) monitoring blast cell test before HSCT has a certain guiding significance for prognostic assessment.

Ni2 Se3 -CuSex Heterostructure as a Highly Efficient Bifunctional Electrocatalyst for Urea-Assisted Hydrogen Generation

Coupling urea oxidation reaction (UOR) with hydrogen evolution reaction (HER) is an attractive alternative anode reaction for electrochemical hydrogen generation with low energy consumption. However, the development of highly efficient bifunctional electrocatalysts is still a challenge. In this work, Ni₂ Se₃ -CuSe_x heterostructure was synthesized on copper foam (Ni₃ Se₂ @CuSe_x /CF) by electrodeposition accompanied by a selenization process. Benefiting from the abundant active sites, faster reaction kinetics, and modulated electronic structure, the self-supporting Ni₃ Se₂ @CuSe_x /CF electrode exhibited superior catalytic performance. Extremely low overpotentials of 120 and 140 mV were achieved at the current density of 100 mA cm^-2 for HER/UOR, respectively. Respectively, in HER||UOR coupled electrolyzer for H₂ generation, the Ni₃ Se₂ @CuSe_x /CF||Ni₃ Se₂ @CuSe_x /CF delivered a low cell voltage of 1.49 V to reach a high current density of 100 mA cm^-2 along with good stability, outperforming most of the other well-developed materials to date. The rational design of coupled heterostructure as bifunctional electrodes is a promising approach for energy-saving H₂ production.

[The impact of diabetic retinopathy on vision-related quality of life]

Objective: To assess the effect of diabetic retinopathy (DR) on vision-related quality of life (VRQoL) in patients with type 2 diabetes. Methods: In this cross-sectional study, patients with type 2 diabetes residing in 15 residency communities in Fushun, Liaoning province were enrolled from July 2012 to May 2013. We measured the VRQoL by the 25-item National Eye Institute Visual Function Questionnaire (NEI-VFQ-25). Patients were grouped according to their age, gender, presence of visual impairment, and affected eyes. NEI-VFQ-25 scores were compared between/among groups using the Wilcoxon rank-sum test or Kruskal-Wallis H test. The severity of DR in the eyes was graded into no DR, mild non-proliferative diabetic retinopathy (NPDR), moderate NPDR, severe NPDR, and proliferative diabetic retinopathy (PDR). Severity scores from both eyes were then summarized to create a single per-person grade ranging from 1 (no DR in either eye) to 7 (bilateral PDR). Generalized linear models were used to assess the linear relationship between NEI-VFQ-25 scores and DR severity. Locally weighted scatterplot smoothing plots were generated to evaluate the possible nonlinear associations between concatenated severity of DR and VRQoL. Results: A total of 1 537 patients were recruited, including 836 (54.4%) with no DR, 479 (31.2%) with mild NPDR, 90 (5.9%) with moderate NPDR, 72 (4.7%) with severe NPDR and 60 (3.9%) with PDR. Compared with patients with unilateral DR, bilaterally involved subjects were statistically significantly compromised in general vision [70.2 (66.5, 72.5) vs. 68.9 (63.9, 71.6), Z=90.222, P=0.038], near activities [90.5 (85.8, 94.0) vs. 88.8 (84.5, 92.5), Z=114.942, P=0.005], dependency [91.1 (85.6, 96.5) vs. 89.3 (83.8, 94.5), Z=91.934, P=0.033], mental health [80.0 (73.4, 84.9) vs. 77.5 (70.8, 82.0), Z=118.388, P=0.003], role difficulties [76.8 (70.1, 82.4) vs. 74.5 (67.6, 80.6), Z =90.791, P=0.036] and NEI-VFQ-25 composite [88.3 (84.2, 91.0) vs. 86.9 (82.8, 90.1), Z=96.207, P=0.024]. Scores on general vision (χ²=85.665), near activities (χ²=78.462), distance activities (χ²=145.489), social function (χ²=53.629), dependency (χ²=86.710), mental health (χ²=68.281), role difficulties (χ²=45.357), color vision (χ²=68.176), peripheral vision (χ²=116.179) and NEI-VFQ-25 composite (χ²=133.291) decreased gradually as DR severity increased (all P<0.001). On role difficulties, locally weighted scatterplot smoothing plots showed significant"turning points"from bilateral mild NPDR to mild NPDR/>mild NPDR (slope m=-4.7) and from moderate NPDR/≥moderate NPDR to severe NPDR/≥severe NPDR (slope m=-12.6). Conclusion: Both greater severity and bilaterality of DR were associated with lower vision-specific VRQoL, particularly role difficulties and mental health.

Hierarchical Metal Sulfides Heterostructure as Superior Bifunctional Electrode for Overall Water Splitting

The development of highly active bifunctional electrocatalysts for overall water splitting is of significant importance, but huge challenges remain. The key element depends on engineering the electronic structure and surface properties of material to achieve improved catalytic activity. Herein, a hierarchical nanowire array of metal sulfides heterostructure on nickel foam (FeCoNiS_x /NF) was designed as a novel type of hybrid electrocatalyst for overall water splitting. The hybrid structure endowed plenty of catalytic active sites, strong electronic interactions, and high interfacial charge transferability, leading to superior bifunctional performance. As a result, the FeCoNiS_x /NF catalyst delivered low overpotentials of 97 and 260 mV at the current density of 50 mA cm^-2 for hydrogen and oxygen evolution reactions, respectively. Moreover, the FeCoNiS_x /NF-based water electrolyzer exhibited a small potential of 1.57 V for a high current density of 50 mA cm^-2 . These results indicate the promising application potential of FeCoNiS_x /NF electrode for hydrogen generation. This work provides a new approach to develop robust hybrid materials as the highly active electrode for electrocatalytic water splitting.

[Clinical phenotype analysis of 6 cases of TTC21B gene related nephronophthisis]

Objective: To analyze the clinical characteristics of 6 children with TTC21B-related nephronophthisis to provide reference for early clinical diagnosis. Methods: The general condition, clinical manifestations, laboratory tests and other clinical data of 6 children from 4 families diagnosed with nephronophthisis by genetic testing in Shanghai Children's Hospital from January 2015 to December 2020 were analyzed retrospectively. Results: A total of 6 children (3 males and 3 females) developed proteinuria and progressive renal dysfunction in early infancy. The onset age of proteinuria was 18 (6, 25) months. The age at the onset of renal impairment was 22 (10, 36) months. All 6 children progressed to end-stage renal disease (ESRD) within 10 (4, 65) months of onset. Five children had hypertension, 3 children with abnormal liver function, 2 children with visceral translocation and 1 child with growth retardation. The genetic results suggested that all children carried variations TTC21B gene p.C518R. Conclusions: Children with TTC21B gene p.C518R nephronophthisis had proteinuria and progressed to ESRD at the early stage of life. These nephronophthisis patients commonly presented with liver and renal dysfunction.

How Have Global River Widths Changed Over Time?

Changes in a river's width reflect natural and anthropogenic impacts on local and upstream/downstream hydraulic and hydrologic processes. Temporal variation of river width also impacts biogeochemical exchange and reflects geomorphologic evolution. However, while global maps of mean river width and dynamic water surface extent exist, there is currently no standardized global assessment of river widths that documents changes over time. Therefore, we made repeated width measurements from Landsat images for all rivers wider than 90 m collected from 1984 to 2020 (named Global LOng-term river Width, GLOW), which consists of ∼1.2 billion cross-sectional river width measurements, with an average of 3,000 width measurements per 10-km reach. With GLOW, we investigated the temporal variations of global river width, quantified by the interquartile range (IQR) and temporal trend. We found that 85% of global rivers have a width IQR <150 m. We also found that 37% of global river segments show significant temporal trends in width over the past 37 years, and this number is higher (46%) for human-regulated rivers. Further, we leveraged machine learning to identify the most important factors explaining river width variations and revealed that these driving factors are significantly different between free-flowing and non-free-flowing rivers. Specifically, the most important factor driving temporal variations in river width is the climate for free-flowing rivers, and is soil condition for human-impacted rivers. Finally, we anticipate that this study and the public release of GLOW will improve the understanding of river dynamics and catalyze additional interdisciplinary studies.

Fluorine-anion engineering endows superior bifunctional activity of nickel sulfide/phosphide heterostructure for overall water splitting

Designing advanced transition metal-based materials for electrocatalytic water splitting is of significance, but their wide application is still limited due to the lack of an effective regulation strategy. Herein, a synergistic regulation strategy of surface/interface is developed to optimize the catalytic activity of nickel sulfide (Ni₃S₂). The construction of nickel phosphide with Ni₃S₂ heterostructure by using fluorine (F)-anion modification is successfully developed on nickel foam (F-NiP_x/Ni₃S₂-NF) via a simple fluorination and phosphating treatment. This new kind of electrocatalyst contains plenty of active sites and strong electronic interactions, presenting superior bifunctional activity for both hydrogen evolution reaction (HER) and oxygen evolution reaction (OER). The overpotentials only need 182 mV and 370 mV to reach the current density of 100 mA cm^-2 for HER and OER, respectively. In addition, the F-NiP_x/Ni₃S₂-NF-based electrolyzer delivers promising performance for overall water splitting. A low potential of 1.55 V and 1.7 V can be achieved at the current density of 10 mA cm^-2 and 50 mA cm^-2. This work provides a new surface/interface regulation strategy for high-efficient bifunctional electrocatalysts.

Dual-anions engineering of bimetallic oxides as highly active electrocatalyst for boosted overall water splitting

Bimetallic oxides have unique advantages in driving both oxygen and hydrogen evolution reactions (OER/HER). Surface engineering of bimetallic oxides is a promising way to boost the catalytic activity by the regulation of electronic structure and surface property. Herein, a dual P, S-anions modification strategy is developed to optimize the catalytic performance of CoMoO₄ nanowire arrays. The formations of CoP and Co₃S₄ species on the CoMoO₄ surface bring heterojunction interfaces for more catalytic active sites and strong electronic interaction for faster interfacial charge transfer. Benefiting from these advantages, the P, S-CoMoO₄ catalyst on nickel foam (NF) delivers excellent catalytic activity and stability. The overpotentials at 10 mA cm^-2 of P, S-CoMoO₄/NF for HER are just 31 mV in acid media and 58 mV in alkaline media, respectively. In addition, by assembling the P, S-CoMoO₄/NF as bifunctional electrodes for overall water splitting, the electrolyzer exhibits a voltage of as low as 1.66 V at a current density of 50 mA cm^-2. This work put forward a new avenue for the development of advanced bifunctional electrocatalysts for water splitting.

Electronic regulation of platinum species on metal nitrides realizes superior mass activity for hydrogen production

Developing high-active electrocatalyst to improve the efficiency of hydrogen evolution reaction (HER) is critical to achieve clean hydrogen. However, the low mass activity and high cost of this technology still limits its wide commercial application. Herein, a new kind of hybrid material is designed by introducing trace Pt species onto a mixed metal nitride matrixs (denoted as NiWN_x), presenting as an excellent electrocatalyst for HER. The prepared Pt-NiWN_x hybrid possesses abundant heterointerfaces, high conductivity and strong electron interactions, facilitating the reaction kinetics for hydrogen production. As a result, the Pt-NiWN_x only needs a small overpotential of 61 mV to reach the geometric current density of 100 mA cm^-2 in alkaline electrolyte. Notably, this kind of catalyst delivers a superior mass activity of 32.8 A mg_Pt^-1 at -0.1 V and high durability, exhibiting the promising prospects for industrial application. This work offers a novel design strategy for high-efficient hybrid materials for scaled hydrogen generation.

Buntanetap, a Novel Translational Inhibitor of Multiple Neurotoxic Proteins, Proves to Be Safe and Promising in Both Alzheimer's and Parkinson's Patients

BACKGROUND

Previously we reported the clinical safety and pharmacological activity of buntanetap (known as Posiphen or ANVS401) in healthy volunteers and mild cognitive impaired (MCI) patients (21). The data supported continued clinical evaluation of buntanetap for treating Alzheimer's Disease (AD). Neurodegenerative diseases such as AD and Parkinson's disease (PD) share several pathological manifestations, including increased levels of multiple neurotoxic protein aggregates. Therefore, a treatment strategy that targets toxic species common to both disorders can potentially provide better clinical outcomes than attacking one neurotoxic protein alone. To test this hypothesis, we recently completed a clinical study in early AD and early PD participants and report the data here.

OBJECTIVES

We evaluated safety, pharmacokinetics, biomarkers, and efficacy of buntanetap in treating early AD and PD patients.

DESIGN

Double-blind, placebo-controlled, multi-center study.

SETTING

13 sites in the US participated in this clinical trial. The registration number is NCT04524351 at ClinicalTrials.gov.

PARTICIPANTS

14 early AD patients and 54 early PD patients.

INTERVENTION

AD patients were given either 80mg buntanetap or placebo QD. PD patients were given 5mg, 10mg, 20mg, 40mg, 80mg buntanetap or placebo QD.

MEASUREMENTS

Primary endpoint is safety and tolerability; secondary endpoint is pharmacokinetics of buntanetap in plasma; exploratory endpoints are 1) biomarkers in cerebrospinal fluid (CSF) in both AD and PD patients 2) psychometric tests specific for AD (ADAS-Cogs and WAIS coding test) or PD (MDS-UPDRS and WAIS coding test).

RESULTS

Buntanetap was safe and well tolerated. Biomarker data indicated a trend in lowering levels of neurotoxic proteins and inflammatory factors and improving axonal integrity and synaptic function in both AD and PD cohorts. Psychometric tests showed statistically significant improvements in ADAS-Cog11 and WAIS coding in AD patients and MDS-UPDRS and WAIS coding in PD patients.

CONCLUSIONS

Buntanetap is well tolerated and safe at doses up to 80mg QD in both AD and PD patients. Cmax and AUC increase with dose without evidence for a plateau up to 80mg QD. The drug shows promising evidence in exploratory biomarker and efficacy measures. Further evaluation of buntanetap in larger, longer-term clinical trials for the treatment of AD and PD are warranted.

Hierarchically structured nickel/molybdenum nitride heterojunctions as superior bifunctional electrodes for overall water splitting

A 3D hierarchical heterostructure of intermetallic compound heterojunctions is first rationally designed and presented as a highly-active bifunctional electrode for water splitting.

[G-protein coupled receptor Smo positively regulates proliferation and migration of adult neural stem cells in vitro]

OBJECTIVE

To investigate the role of G-protein coupled receptor Smoothened (Smo) in regulating proliferation and migration of adult neural stem cells (ANSCs) and explore the underlying mechanism.

METHODS

Cultured ANSCs were treated with purmorphamine (PM, an agonist of Smo) or cyclopamine (CPM, an inhibitor of Smo), and the changes in cell proliferation migration abilities were assessed using cell counting kit-8 (CCK8) assay and wound healing assay, respectively. The mRNA expressions of membrane receptor Patched 1 (Ptch1), Smo, glioma-associated oncogene homolog 1 (Gli1), axon guidance cue slit1 (Slit1) and brain-derived neurotrophic factor (BDNF) in the treated cells were detected using real-time quantitative PCR (RT-PCR).

RESULTS

PM significantly promoted the proliferation (P < 0.01) and migration of ANSCs (P < 0.01), and up-regulated the mRNA expressions of Ptch1, Smo, Gli1, Slit1 and BDNF. Treatment with CPM significantly inhibited the proliferation and migration of ANSCs.

CONCLUSION

Modulating Smo activity can positively regulate the proliferation and migration of ANSCs possibly by regulating the expressions of BDNF and Slit1.

Highly efficient electrochemical reduction of carbon dioxide to formate on Sn modified Bi2O3 heterostructure

In this work, Sn species are deposited onto the surface of a Bi₂O₃ material by a facile disproportionated reaction and the prepared catalyst shows a superior electrocatalytic performance towards CO₂ reduction. The deposition of Sn atoms can donate electrons to the Bi₂O₃ material and increase its electrical conductivity. The Sn_M-Bi₂O₃ catalyst with the optimal Sn content delivers a high faradaic efficiency of 95.8% at -1.0 V for formate production. In addition, the partial current density of formate can reach 41.8 mA cm^-2. The Sn_M-Bi₂O₃ catalyst also exhibits superior stability towards long-term electrolysis. The modification of Sn species not only helps to stabilize the reaction intermediate but also inhibits the hydrogen evolution reaction (HER) pathway, achieving the synergetic enhancement of catalytic activity.

Insight into biosorption of heavy metals by extracellular polymer substances and the improvement of the efficacy: a review

Heavy metals are continuously released into aquatic environments in which they accumulate. This phenomenon endangers public health because heavy metals accumulate along the food chain. However, conventional remediation methods are inefficient, expensive and yield toxic intermediate products, which adversely affect the environment. The discovery of green bio-adsorbents such as microbial extracellular polymer substance (EPS) has quickly attracted considerable worldwide attention because of their low cost, high removal efficiency of heavy metals and industrial availability. Hence, this review considers the sources, hazards and treatment methods of heavy metals pollution, particularly the biosorption mechanism of EPS to heavy metals and the influencing factors of the bio-adsorption process, which are significant in the efficient removal of heavy metals-containing wastewater treatment. This review also focuses on strengthening the process of EPS adsorption of heavy metals, which can further contribute to heavy metals removal. Finally, it has been proposed that improving the yield, stability, selectivity and recoverability of EPS is the key direction of further research.

POS1047 IMPACT OF UPADACITINIB ON REDUCING PAIN IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: RESULTS FROM TWO PHASE 3 TRIALS IN PATIENTS WITH INADEQUATE RESPONSE TO NON-BIOLOGIC OR BIOLOGIC DMARDs

Background:

Pain is a dominant symptom of psoriatic arthritis (PsA), and pain reduction is a priority for patients (pts) that is often assessed in clinical trials. Upadacitinib (UPA), a Janus kinase (JAK) inhibitor engineered for increased selectivity for JAK1 over JAK2, JAK3, and tyrosine kinase2, has demonstrated safety and efficacy in pts with active PsA in the SELECT-PsA 1 and 2 studies.1,2

Objectives:

The objective of this analysis was to compare the efficacy of UPA vs placebo (PBO) and adalimumab (ADA) on pain using different assessments through 24 weeks (wks).

Methods:

The SELECT-PsA program enrolled adult pts with active PsA with prior inadequate response (IR) or intolerance to ≥1 non-biologic DMARD (SELECT-PsA 1; NCT03104400) or prior IR or intolerance to ≥1 biologic DMARD (SELECT-PsA 2; NCT03104374). Concomitant background therapy with ≤2 non-biologic DMARDs was allowed but not required. Pts were randomized to UPA 15 mg or UPA 30 mg once daily (QD) or PBO (both studies), or ADA 40 mg every other week (EOW; SELECT-PsA 1 only). Pain was assessed as proportion of pts achieving ≥30%, ≥50%, or ≥70% reduction from baseline (BL) in Pt’s global assessment (PGA) of pain numeric rating scale (NRS) score (0–10), proportion of pts achieving minimal clinically important difference (MCID) in pain (defined as ≥1 point reduction or 15% reduction from BL on a 0–10 NRS)3,4 and change from baseline in pain NRS (0–10) at all time points. In addition, change from BL in BASDAI questions 2 (spinal pain) and 3 (joint pain/swelling) and 36-Item Short Form Survey (SF-36) questions 7 (bodily pain) and 8 (pain interference) at weeks 12 and 24 were assessed. Non-responder imputation was used for binary endpoints and mixed-effects model for repeated measurements for continuous endpoints. The statistical significance defined as P<0.05 was exploratory in nature.

Results:

In both studies, a significantly higher proportion of pts receiving UPA 15 mg QD and UPA 30 mg QD vs PBO achieved improvements in most pain endpoints as early as wk 2, and improvements were generally either sustained or increased through wk 24 (nominal P<0.05). A significant improvement with UPA vs PBO was also observed for change from BL in PGA of pain NRS scores over time, as well as in BASDAI spinal pain and joint pain/swelling and SF-36 bodily pain and pain interference at weeks 12 and 24. In SELECT-PsA 1 significantly higher proportions of pts receiving UPA 30 mg QD vs ADA 40 mg EOW achieved improvements in most pain assessments as early as wk 2 which were sustained through wk 24; improvements in several assessments were also significantly greater with UPA 15 mg QD vs ADA 40 mg EOW at wk 24 (nominal P <0.05; Data will be presented).

Conclusion:

In pts with active PsA who had inadequate response to non-biologic or biologic DMARDs, a greater proportion of pts treated with UPA vs PBO achieved rapid, significant, and clinically meaningful reductions in pain across multiple pain assessments. The reductions in pain were sustained over 24 wks.

References:

[1]McInnes I. et al. Ann Rheum Dis. 2020;79(Suppl 1):12-13.

[2]Genovese M.C. et al. Ann Rheum Dis. 2020;79(Suppl 1):139.

[3]Dworkin, R.H. et al. J Pain. 2008;9(2):105-121.

[4]Salaffi F. et al. Eur J Pain. 2004;8:283–291.

Acknowledgements:

AbbVie funded this study and participated in the study design, research, analysis, data collection, interpretation of data, reviewing, and approval of the publication. All authors had access to relevant data and participated in the drafting, review, and approval of this publication. No honoraria or payments were made for authorship. Medical writing support was provided by M Hovenden and J Matsuura of ICON plc (North Wales, PA) and was funded by AbbVie.

Disclosure of Interests:

Iain McInnes Consultant of: AbbVie, AstraZeneca, Boehringer Ingelheim, Bristol Myers, Celgene, Janssen, Leo, Lilly, Novartis, Pfizer, and UCB, Grant/research support from: AbbVie, AstraZeneca, Boehringer Ingelheim, Bristol Myers, Celgene, Janssen, Leo, Lilly, Novartis, Pfizer, and UCB, William Tillett Speakers bureau: AbbVie, Amgen, Celgene, Janssen, Lilly, MSD, Novartis, Pfizer, and UCB, Consultant of: AbbVie, Amgen, Celgene, Janssen, Lilly, MSD, Novartis, Pfizer, and UCB, Philip J Mease Speakers bureau: AbbVie, Amgen, Boehringer Ingelheim, Bristol Myers, Celgene, Galapagos, Genentech, Gilead, GlaxoSmithKline, Janssen, Leo, Lilly, Merck, Novartis, Pfizer, Sun Pharma, and UCB, Consultant of: AbbVie, Amgen, Boehringer Ingelheim, Bristol Myers, Celgene, Galapagos, Genentech, Gilead, GlaxoSmithKline, Janssen, Leo, Lilly, Merck, Novartis, Pfizer, Sun Pharma, and UCB, Grant/research support from: AbbVie, Amgen, Boehringer Ingelheim, Bristol Myers, Celgene, Galapagos, Genentech, Gilead, GlaxoSmithKline, Janssen, Leo, Lilly, Merck, Novartis, Pfizer, Sun Pharma, and UCB, Kurt de Vlam Speakers bureau: Celgene Eli Lilly, Galapagos, Novartis, and UCB, Consultant of: Celgene, Eli Lilly, Galapagos, Novartis, and UCB, Grant/research support from: Celgene and Galapagos, Louis Bessette Speakers bureau: Amgen, BMS, Janssen, UCB, AbbVie, Pfizer, Merck, Celgene, Lilly, Novartis, and Sanofi, Consultant of: Amgen, BMS, Janssen, UCB, AbbVie, Pfizer, Merck, Celgene, Lilly, Novartis, Sanofi, Gilead, Grant/research support from: Amgen, BMS, Janssen, UCB, AbbVie, Pfizer, Merck, Celgene, Lilly, Novartis, Sanofi, and Gilead, Ralph Lippe Shareholder of: AbbVie, Employee of: AbbVie, anna maniccia Shareholder of: AbbVie, Employee of: AbbVie, Patrick Zueger Shareholder of: AbbVie, Employee of: AbbVie, Dai Feng Shareholder of: AbbVie, Employee of: AbbVie, Koji Kato Shareholder of: AbbVie, Employee of: AbbVie, Andrew Ostor Consultant of: AbbVie, BMS, Roche, Janssen, Lilly, Novartis, Pfizer, UCB, Gilead, and Paradigm.